25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PHCUF (Photocure) Stock Analysis
Buy, Hold or Sell?

Let's analyze Photocure together

I guess you are interested in Photocure ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Photocure’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Photocure’s Price Targets

I'm going to help you getting a better view of Photocure ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Photocure ASA

I send you an email if I find something interesting about Photocure ASA.

1. Quick Overview

1.1. Quick analysis of Photocure (30 sec.)










1.2. What can you expect buying and holding a share of Photocure? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.72
Expected worth in 1 year
$1.67
How sure are you?
46.9%

+ What do you gain per year?

Total Gains per Share
$-0.05
Return On Investment
-1.1%

For what price can you sell your share?

Current Price per Share
$4.32
Expected price per share
$4.32 - $4.32
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Photocure (5 min.)




Live pricePrice per Share (EOD)
$4.32
Intrinsic Value Per Share
$1.39 - $1.64
Total Value Per Share
$3.11 - $3.36

2.2. Growth of Photocure (5 min.)




Is Photocure growing?

Current yearPrevious yearGrowGrow %
How rich?$47.3m$15m$31.8m67.9%

How much money is Photocure making?

Current yearPrevious yearGrowGrow %
Making money-$113.7k$284.2k-$398k-350.0%
Net Profit Margin-1.3%-0.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Photocure (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Photocure?

Welcome investor! Photocure's management wants to use your money to grow the business. In return you get a share of Photocure.

First you should know what it really means to hold a share of Photocure. And how you can make/lose money.

Speculation

The Price per Share of Photocure is $4.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Photocure.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Photocure, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.72. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Photocure.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.02-0.5%0.00-0.1%0.010.3%-0.02-0.5%-0.01-0.3%
Usd Book Value Change Per Share-0.06-1.3%-0.01-0.3%0.409.3%0.051.1%0.051.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-1.3%-0.01-0.3%0.409.3%0.051.1%0.051.2%
Usd Price Per Share5.60-5.29-6.68-9.31-6.36-
Price to Earnings Ratio-70.47--46.38-54.39--23.94--27.11-
Price-to-Total Gains Ratio-100.80-12.15-7,938.94-1,691.77-1,438.07-
Price to Book Ratio3.26-3.07-34.74-21.20-14.71-
Price-to-Total Gains Ratio-100.80-12.15-7,938.94-1,691.77-1,438.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.32
Number of shares231
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.05
Usd Total Gains Per Share-0.010.05
Gains per Quarter (231 shares)-2.7411.27
Gains per Year (231 shares)-10.9745.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-11-2104535
20-22-3209080
30-33-430135125
40-44-540180170
50-55-650225215
60-66-760271260
70-77-870316305
80-88-980361350
90-99-1090406395
100-110-1200451440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%7.025.00.021.9%7.025.00.021.9%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.09.02.045.0%15.015.02.046.9%15.015.02.046.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.032.00.0%0.00.032.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.09.02.045.0%15.015.02.046.9%15.015.02.046.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Photocure ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.056-0.012-79%0.400-114%0.049-214%0.054-204%
Book Value Per Share--1.7181.7250%0.555+209%1.182+45%0.930+85%
Current Ratio--4.4895.053-11%4.527-1%5.025-11%4.867-8%
Debt To Asset Ratio--0.3180.312+2%0.329-3%0.311+2%0.265+20%
Debt To Equity Ratio--0.4660.454+3%0.498-6%0.459+1%0.376+24%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--160034134.600148817704.931+8%182312957.113-12%243881208.914-34%245804967.082-35%
Eps---0.020-0.004-78%0.015-234%-0.0200%-0.013-33%
Ev To Ebitda Ratio--28.79025.154+14%149.228-81%infnan%infnan%
Ev To Sales Ratio--2.9853.016-1%35.213-92%infnan%infnan%
Free Cash Flow Per Share--0.0380.063-40%0.020+86%0.015+161%0.015+161%
Free Cash Flow To Equity Per Share--0.0000.026-99%0.003-92%-0.004+1949%-0.004+1949%
Gross Profit Margin--17.95612.060+49%6.391+181%12.294+46%8.059+123%
Intrinsic Value_10Y_max--1.638--------
Intrinsic Value_10Y_min--1.391--------
Intrinsic Value_1Y_max--0.098--------
Intrinsic Value_1Y_min--0.096--------
Intrinsic Value_3Y_max--0.344--------
Intrinsic Value_3Y_min--0.328--------
Intrinsic Value_5Y_max--0.652--------
Intrinsic Value_5Y_min--0.601--------
Market Cap114940944.000-34%154293333.600143831670.055+7%180954996.675-15%250967277.066-39%181578159.791-15%
Net Profit Margin---0.041-0.013-68%-0.008-80%-0.059+45%-0.085+109%
Operating Margin--0.0520.074-29%0.224-77%0.062-15%-0.004+107%
Operating Ratio--1.0000.890+12%0.762+31%0.852+17%1.017-2%
Pb Ratio2.515-30%3.2603.071+6%34.743-91%21.204-85%14.707-78%
Pe Ratio-54.364+23%-70.472-46.375-34%54.391-230%-23.943-66%-27.112-62%
Price Per Share4.320-30%5.6005.288+6%6.675-16%9.314-40%6.358-12%
Price To Free Cash Flow Ratio28.497-30%36.94136.005+3%-45.478+223%2529.202-99%1580.751-98%
Price To Total Gains Ratio-77.761+23%-100.80112.154-929%7938.937-101%1691.772-106%1438.073-107%
Quick Ratio--3.8574.406-12%6.294-39%2.994+29%2.240+72%
Return On Assets---0.008-0.002-80%0.000-2651%-0.012+54%-0.013+63%
Return On Equity---0.012-0.003-78%0.000-7873%-0.017+48%-0.017+49%
Total Gains Per Share---0.056-0.012-79%0.400-114%0.049-214%0.054-204%
Usd Book Value--47323366.20046891777.350+1%15060936.579+214%31869812.963+48%27108512.332+75%
Usd Book Value Change Per Share---0.056-0.012-79%0.400-114%0.049-214%0.054-204%
Usd Book Value Per Share--1.7181.7250%0.555+209%1.182+45%0.930+85%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--160034134.600148817704.931+8%182312957.113-12%243881208.914-34%245804967.082-35%
Usd Eps---0.020-0.004-78%0.015-234%-0.0200%-0.013-33%
Usd Free Cash Flow--1044194.8001696627.350-38%552267.114+89%357630.168+192%223518.855+367%
Usd Free Cash Flow Per Share--0.0380.063-40%0.020+86%0.015+161%0.015+161%
Usd Free Cash Flow To Equity Per Share--0.0000.026-99%0.003-92%-0.004+1949%-0.004+1949%
Usd Market Cap114940944.000-34%154293333.600143831670.055+7%180954996.675-15%250967277.066-39%181578159.791-15%
Usd Price Per Share4.320-30%5.6005.288+6%6.675-16%9.314-40%6.358-12%
Usd Profit---547355.600-113732.850-79%284298.258-293%-345470.260-37%-341245.723-38%
Usd Revenue--13402833.40012425378.900+8%4166289.101+222%6253538.222+114%5745717.590+133%
Usd Total Gains Per Share---0.056-0.012-79%0.400-114%0.049-214%0.054-204%
 EOD+4 -4MRQTTM+10 -28YOY+13 -255Y+18 -1810Y+20 -16

3.3 Fundamental Score

Let's check the fundamental score of Photocure ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-54.364
Price to Book Ratio (EOD)Between0-12.515
Net Profit Margin (MRQ)Greater than0-0.041
Operating Margin (MRQ)Greater than00.052
Quick Ratio (MRQ)Greater than13.857
Current Ratio (MRQ)Greater than14.489
Debt to Asset Ratio (MRQ)Less than10.318
Debt to Equity Ratio (MRQ)Less than10.466
Return on Equity (MRQ)Greater than0.15-0.012
Return on Assets (MRQ)Greater than0.05-0.008
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Photocure ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than504.338
Ma 20Greater thanMa 504.320
Ma 50Greater thanMa 1004.729
Ma 100Greater thanMa 2004.805
OpenGreater thanClose4.320
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira, as well as strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) reusable flexible blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

Fundamental data was last updated by Penke on 2025-04-05 19:28:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Photocure earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -4.1%Β means thatΒ $-0.04 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Photocure ASA:

  • The MRQ is -4.1%. The company is making a loss. -1
  • The TTM is -1.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-1.3%-2.8%
TTM-1.3%YOY-0.8%-0.5%
TTM-1.3%5Y-5.9%+4.6%
5Y-5.9%10Y-8.5%+2.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Photocure is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -0.8% Return on Assets means thatΒ Photocure generatedΒ $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Photocure ASA:

  • The MRQ is -0.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-0.2%-0.6%
TTM-0.2%YOY0.0%-0.2%
TTM-0.2%5Y-1.2%+1.0%
5Y-1.2%10Y-1.3%+0.1%
4.3.1.3. Return on Equity

Shows how efficient Photocure is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Equity means Photocure generated $-0.01Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Photocure ASA:

  • The MRQ is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-0.3%-0.9%
TTM-0.3%YOY0.0%-0.3%
TTM-0.3%5Y-1.7%+1.5%
5Y-1.7%10Y-1.7%+0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Photocure ASA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Photocure is operatingΒ .

  • Measures how much profit Photocure makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 5.2%Β means the company generated $0.05 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Photocure ASA:

  • The MRQ is 5.2%. The company is operating less efficient.
  • The TTM is 7.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.2%TTM7.4%-2.1%
TTM7.4%YOY22.4%-15.0%
TTM7.4%5Y6.2%+1.2%
5Y6.2%10Y-0.4%+6.5%
4.3.2.2. Operating Ratio

Measures how efficient Photocure is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Photocure ASA:

  • The MRQ is 1.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.890. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.000TTM0.890+0.110
TTM0.890YOY0.762+0.128
TTM0.8905Y0.852+0.038
5Y0.85210Y1.017-0.165
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Photocure ASA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Photocure is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.49Β means the company has $4.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Photocure ASA:

  • The MRQ is 4.489. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.053. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.489TTM5.053-0.563
TTM5.053YOY4.527+0.525
TTM5.0535Y5.025+0.028
5Y5.02510Y4.867+0.158
4.4.3.2. Quick Ratio

Measures if Photocure is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.86Β means the company can pay off $3.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Photocure ASA:

  • The MRQ is 3.857. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.406. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.857TTM4.406-0.549
TTM4.406YOY6.294-1.887
TTM4.4065Y2.994+1.413
5Y2.99410Y2.240+0.754
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Photocure ASA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of PhotocureΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Photocure to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32Β means that Photocure assets areΒ financed with 31.8% credit (debt) and the remaining percentage (100% - 31.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Photocure ASA:

  • The MRQ is 0.318. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.312. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.318TTM0.312+0.006
TTM0.312YOY0.329-0.017
TTM0.3125Y0.311+0.001
5Y0.31110Y0.265+0.046
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Photocure is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 46.6% means that company has $0.47 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Photocure ASA:

  • The MRQ is 0.466. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.454. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.466TTM0.454+0.012
TTM0.454YOY0.498-0.044
TTM0.4545Y0.459-0.006
5Y0.45910Y0.376+0.083
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Photocure generates.

  • Above 15 is considered overpriced butΒ always compareΒ Photocure to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -70.47 means the investor is paying $-70.47Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Photocure ASA:

  • The EOD is -54.364. Based on the earnings, the company is expensive. -2
  • The MRQ is -70.472. Based on the earnings, the company is expensive. -2
  • The TTM is -46.375. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-54.364MRQ-70.472+16.108
MRQ-70.472TTM-46.375-24.097
TTM-46.375YOY54.391-100.766
TTM-46.3755Y-23.943-22.432
5Y-23.94310Y-27.112+3.169
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Photocure ASA:

  • The EOD is 28.497. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 36.941. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 36.005. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD28.497MRQ36.941-8.444
MRQ36.941TTM36.005+0.935
TTM36.005YOY-45.478+81.484
TTM36.0055Y2,529.202-2,493.197
5Y2,529.20210Y1,580.751+948.451
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Photocure is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.26 means the investor is paying $3.26Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Photocure ASA:

  • The EOD is 2.515. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.260. Based on the equity, the company is fair priced.
  • The TTM is 3.071. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.515MRQ3.260-0.745
MRQ3.260TTM3.071+0.189
TTM3.071YOY34.743-31.672
TTM3.0715Y21.204-18.133
5Y21.20410Y14.707+6.496
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Total Other Income Expense Net -2,557-25-2,58188-2,4942,233-261372111



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets733,414
Total Liabilities233,167
Total Stockholder Equity500,247
 As reported
Total Liabilities 233,167
Total Stockholder Equity+ 500,247
Total Assets = 733,414

Assets

Total Assets733,414
Total Current Assets419,776
Long-term Assets313,637
Total Current Assets
Cash And Cash Equivalents 293,852
Net Receivables 66,856
Inventory 39,536
Total Current Assets  (as reported)419,776
Total Current Assets  (calculated)400,244
+/- 19,532
Long-term Assets
Property Plant Equipment 20,803
Goodwill 144,000
Intangible Assets 111,235
Other Assets 1
Long-term Assets  (as reported)313,637
Long-term Assets  (calculated)276,039
+/- 37,598

Liabilities & Shareholders' Equity

Total Current Liabilities93,511
Long-term Liabilities139,656
Total Stockholder Equity500,247
Total Current Liabilities
Accounts payable 19,443
Other Current Liabilities 74,068
Total Current Liabilities  (as reported)93,511
Total Current Liabilities  (calculated)93,511
+/-0
Long-term Liabilities
Long-term Liabilities Other 139,656
Long-term Liabilities  (as reported)139,656
Long-term Liabilities  (calculated)139,656
+/-0
Total Stockholder Equity
Common Stock13,560
Retained Earnings 9,145
Other Stockholders Equity 477,542
Total Stockholder Equity (as reported)500,247
Total Stockholder Equity (calculated)500,247
+/-0
Other
Capital Stock13,560
Cash and Short Term Investments 293,852
Common Stock Shares Outstanding 27,552
Liabilities and Stockholders Equity 733,414
Net Debt -293,852
Net Invested Capital 500,247
Net Working Capital 326,265
Property Plant and Equipment Gross 20,803



6.3. Balance Sheets Structured

Currency in NOK. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
278,129
269,980
259,556
263,099
250,259
278,631
228,530
231,196
232,404
220,989
216,606
257,352
0
0
608,392
776,047
766,893
777,248
779,870
789,648
738,111
74,034
67,288
73,306
67,383
65,755
65,917
711,264
714,611
713,582
720,470
733,414
733,414720,470713,582714,611711,26465,91765,75567,38373,30667,28874,034738,111789,648779,870777,248766,893776,047608,39200257,352216,606220,989232,404231,196228,530278,631250,259263,099259,556269,980278,129
   > Total Current Assets 
199,865
191,053
170,480
175,613
159,229
176,792
142,769
153,429
147,472
138,586
143,470
186,876
185,377
556,320
381,673
412,246
413,016
424,904
414,248
413,189
362,214
37,444
34,617
36,521
33,309
33,610
33,432
372,431
380,833
387,636
398,384
419,776
419,776398,384387,636380,833372,43133,43233,61033,30936,52134,61737,444362,214413,189414,248424,904413,016412,246381,673556,320185,377186,876143,470138,586147,472153,429142,769176,792159,229175,613170,480191,053199,865
       Cash And Cash Equivalents 
155,466
137,021
123,092
125,295
110,747
113,943
92,828
23,389
91,405
86,664
95,906
125,320
0
0
321,842
329,526
329,388
340,171
330,143
319,039
285,480
27,544
26,071
27,330
23,484
24,097
23,827
259,504
258,268
266,993
291,051
293,852
293,852291,051266,993258,268259,50423,82724,09723,48427,33026,07127,544285,480319,039330,143340,171329,388329,526321,84200125,32095,90686,66491,40523,38992,828113,943110,747125,295123,092137,021155,466
       Short-term Investments 
0
0
0
0
0
0
0
79,114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
192,661
0
0
0
0
0000192,661000000000000000000079,1140000000
       Net Receivables 
29,964
38,447
32,519
26,692
30,703
0
32,916
28,014
37,436
31,713
29,505
45,146
40,902
34,225
32,242
47,681
56,062
57,742
55,820
52,908
54,657
6,578
5,826
5,557
7,284
6,790
53,785
59,704
70,924
72,037
62,559
66,856
66,85662,55972,03770,92459,70453,7856,7907,2845,5575,8266,57854,65752,90855,82057,74256,06247,68132,24234,22540,90245,14629,50531,71337,43628,01432,916030,70326,69232,51938,44729,964
       Inventory 
14,436
15,585
14,869
19,552
17,779
62,849
17,025
18,582
18,630
20,209
18,059
16,410
16,905
22,674
27,589
29,678
27,566
26,991
28,285
27,534
22,077
3,321
2,720
2,705
2,541
2,722
3,101
37,190
33,307
34,702
33,207
39,536
39,53633,20734,70233,30737,1903,1012,7222,5412,7052,7203,32122,07727,53428,28526,99127,56629,67827,58922,67416,90516,41018,05920,20918,63018,58217,02562,84917,77919,55214,86915,58514,436
       Other Current Assets 
-1
0
0
4,074
0
0
0
4,330
1
0
0
4,118
0
0
0
5,361
0
0
0
3,856
0
0
-1
929
0
0
45,921
19,201
18,334
13,904
74,126
86,388
86,38874,12613,90418,33419,20145,92100929-1003,8560005,3610004,1180014,3300004,07400-1
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
226,720
363,801
353,877
352,344
365,622
376,459
375,897
36,590
32,671
36,784
34,074
32,145
32,486
338,833
333,778
325,946
322,086
313,637
313,637322,086325,946333,778338,83332,48632,14534,07436,78432,67136,590375,897376,459365,622352,344353,877363,801226,72000000000000000
       Property Plant Equipment 
1,484
1,502
1,495
1,268
1,229
0
1,811
2,141
11,439
10,536
10,013
9,048
9,323
8,091
6,922
5,795
5,410
11,152
24,159
32,418
30,739
3,233
3,008
3,141
3,275
3,195
3,434
33,529
35,805
23,538
21,678
20,803
20,80321,67823,53835,80533,5293,4343,1953,2753,1413,0083,23330,73932,41824,15911,1525,4105,7956,9228,0919,3239,04810,01310,53611,4392,1411,81101,2291,2681,4951,5021,484
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
144,000
144,000
144,000
144,000
144,000
144,000
14,526
13,225
14,681
13,745
13,401
13,452
144,000
144,000
144,000
144,000
144,000
144,000144,000144,000144,000144,00013,45213,40113,74514,68113,22514,526144,000144,000144,000144,000144,000144,000000000000000000
       Intangible Assets 
28,382
28,143
34,849
33,315
30,947
0
25,414
2,396
19,569
16,636
14,056
11,605
0
0
170,644
162,552
159,735
155,379
151,465
147,037
142,736
137,545
25,474
130,881
126,685
123,280
123,543
121,937
119,431
116,569
113,035
111,235
111,235113,035116,569119,431121,937123,543123,280126,685130,88125,474137,545142,736147,037151,465155,379159,735162,552170,6440011,60514,05616,63619,5692,39625,414030,94733,31534,84928,14328,382
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
-1
-1
0
-1
-1
-253,144
-13,225
1
-13,745
-1
-13,453
48,769
108,369
41,839
0
-1
-1041,839108,36948,769-13,453-1-13,7451-13,225-253,144-1-10-1-10-100000000000000
> Total Liabilities 
32,221
28,997
28,832
45,019
46,395
58,543
45,909
54,854
60,606
54,246
50,253
48,762
0
0
116,623
267,915
236,851
251,555
257,190
287,015
257,112
26,142
23,245
26,130
23,923
22,246
22,109
205,217
231,514
213,917
220,740
233,167
233,167220,740213,917231,514205,21722,10922,24623,92326,13023,24526,142257,112287,015257,190251,555236,851267,915116,6230048,76250,25354,24660,60654,85445,90958,54346,39545,01928,83228,99732,221
   > Total Current Liabilities 
28,267
24,762
24,308
40,267
41,407
52,723
33,648
52,453
48,551
42,954
39,464
38,725
39,756
56,558
58,669
79,781
71,834
86,360
80,981
113,583
80,343
9,051
7,710
10,609
8,115
7,165
7,412
77,537
80,197
66,651
77,259
93,511
93,51177,25966,65180,19777,5377,4127,1658,11510,6097,7109,05180,343113,58380,98186,36071,83479,78158,66956,55839,75638,72539,46442,95448,55152,45333,64852,72341,40740,26724,30824,76228,267
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,522
1,722
2,792
597
0
0
5,613
0
0
0
0
00005,613005972,7921,7222,522000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,500
0
0
18,750
25,000
25,000
25,000
18,750
12,500
6,250
0
0
0
0
0
0
0
00000006,25012,50018,75025,00025,00025,00018,7500012,500000000000000000
       Accounts payable 
0
0
0
15,081
0
0
0
10,182
0
0
0
5,121
0
0
0
23,316
12,557
19,082
20,187
23,648
14,739
1,902
1,151
2,170
1,717
1,007
24,026
19,660
12,989
16,206
16,934
19,443
19,44316,93416,20612,98919,66024,0261,0071,7172,1701,1511,90214,73923,64820,18719,08212,55723,3160005,12100010,18200015,081000
       Other Current Liabilities 
28,267
24,762
24,308
3,694
41,407
52,723
33,648
11,407
48,551
42,954
39,464
3,883
39,756
56,558
58,669
5,356
59,277
67,278
60,794
16,214
65,604
4,627
4,837
5,180
5,801
6,158
55,314
56,645
67,208
50,445
60,325
74,068
74,06860,32550,44567,20856,64555,3146,1585,8015,1804,8374,62765,60416,21460,79467,27859,2775,35658,66956,55839,7563,88339,46442,95448,55111,40733,64852,72341,4073,69424,30824,76228,267
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,954
188,134
165,017
165,195
176,209
173,431
176,769
17,091
15,534
15,521
15,808
15,080
14,697
127,680
151,317
147,266
143,481
139,656
139,656143,481147,266151,317127,68014,69715,08015,80815,52115,53417,091176,769173,431176,209165,195165,017188,13457,95400000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,986
3,887
0
0
0
29,644
0
-2,522
-1,722
24,246
-597
0
0
13,974
0
0
0
0
000013,97400-59724,246-1,722-2,522029,6440003,8874,98600000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
143,668
133,767
140,195
151,209
133,598
170,519
169,431
33,343
126,234
165,616
162,051
157,321
127,681
151,318
147,267
143,481
139,656
139,656143,481147,267151,318127,681157,321162,051165,616126,23433,343169,431170,519133,598151,209140,195133,767143,668-100000000000000
       Deferred Long Term Liability 
0
0
0
0
1,495
0
996
20,853
498
249
0
9,628
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000009,628024949820,85399601,4950000
> Total Stockholder Equity
245,908
240,983
230,724
218,080
203,864
220,088
182,621
176,342
171,798
166,743
166,353
208,590
0
0
491,769
508,132
530,042
525,693
522,680
502,633
480,999
47,892
44,043
47,176
43,461
43,510
43,809
482,137
483,096
499,665
499,730
500,247
500,247499,730499,665483,096482,13743,80943,51043,46147,17644,04347,892480,999502,633522,680525,693530,042508,132491,76900208,590166,353166,743171,798176,342182,621220,088203,864218,080230,724240,983245,908
   Common Stock
10,779
10,779
10,779
10,779
10,779
220,088
10,797
10,890
10,898
10,898
10,898
10,898
10,898
13,305
13,314
13,359
13,410
13,459
13,472
13,487
13,488
1,368
1,245
1,382
1,294
1,262
1,267
13,560
13,560
13,560
13,560
13,560
13,56013,56013,56013,56013,5601,2671,2621,2941,3821,2451,36813,48813,48713,47213,45913,41013,35913,31413,30510,89810,89810,89810,89810,89810,89010,797220,08810,77910,77910,77910,77910,779
   Retained Earnings 
179,535
174,831
164,123
149,148
135,305
0
113,632
101,691
96,639
91,583
91,194
133,523
115,232
110,496
103,895
111,121
126,377
115,040
107,580
80,496
52,819
3,897
3,263
881
-164
531
244
8,005
5,181
17,402
14,481
9,145
9,14514,48117,4025,1818,005244531-1648813,2633,89752,81980,496107,580115,040126,377111,121103,895110,496115,232133,52391,19491,58396,639101,691113,6320135,305149,148164,123174,831179,535
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
413
0
0
-1
105
0
1
0
-92
0
0
-1
-774
0
-1
0
-2,084
0
42,627
-1,245
44,901
-1,294
-1,262
27,641
460,572
464,355
468,702
471,689
477,542
477,542471,689468,702464,355460,57227,641-1,262-1,29444,901-1,24542,6270-2,0840-10-774-100-92010105-100413000



6.4. Balance Sheets

Currency in NOK. All numbers in thousands.




6.5. Cash Flows

Currency in NOK. All numbers in thousands.




6.6. Income Statements

Currency in NOK. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in NOK. All numbers in thousands.

Gross Profit (+$)
totalRevenue525,388
Cost of Revenue-30,716
Gross Profit494,672494,672
 
Operating Income (+$)
Gross Profit494,672
Operating Expense-494,672
Operating Income20,4000
 
Operating Expense (+$)
Research Development3,631
Selling General Administrative355,038
Selling And Marketing Expenses355,038
Operating Expense494,672713,707
 
Net Interest Income (+$)
Interest Income24,892
Interest Expense-36,901
Other Finance Cost-0
Net Interest Income-12,009
 
Pretax Income (+$)
Operating Income20,400
Net Interest Income-12,009
Other Non-Operating Income Expenses-
Income Before Tax (EBT)8,39012,010
EBIT - interestExpense = 8,390
8,389
32,091
Interest Expense36,901
Earnings Before Interest and Taxes (EBIT)45,29145,291
Earnings Before Interest and Taxes (EBITDA)74,089
 
After tax Income (+$)
Income Before Tax8,390
Tax Provision-13,199
Net Income From Continuing Ops-4,809-4,809
Net Income-4,810
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses525,388
Total Other Income/Expenses Net8,39012,009
 

Technical Analysis of Photocure
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Photocure. The general trend of Photocure is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Photocure's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Photocure Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Photocure ASA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.32 < 4.32 < 4.32.

The bearish price targets are: 4.32 > 4.32 > 4.32.

Know someone who trades $PHCUF? Share this with them.πŸ‘‡

Photocure ASA Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Photocure ASA. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Photocure ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Photocure ASA. The current macd is -0.10283349.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Photocure price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Photocure. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Photocure price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Photocure ASA Daily Moving Average Convergence/Divergence (MACD) ChartPhotocure ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Photocure ASA. The current adx is 80.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Photocure shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Photocure ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Photocure ASA. The current sar is 5.09243485.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Photocure ASA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Photocure ASA. The current rsi is 4.33756176. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Photocure ASA Daily Relative Strength Index (RSI) ChartPhotocure ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Photocure ASA. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Photocure price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Photocure ASA Daily Stochastic Oscillator ChartPhotocure ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Photocure ASA. The current cci is 66.67.

Photocure ASA Daily Commodity Channel Index (CCI) ChartPhotocure ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Photocure ASA. The current cmo is -98.8832242.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Photocure ASA Daily Chande Momentum Oscillator (CMO) ChartPhotocure ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Photocure ASA. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Photocure ASA Daily Williams %R ChartPhotocure ASA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Photocure ASA.

Photocure ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Photocure ASA. The current atr is 0.01031167.

Photocure ASA Daily Average True Range (ATR) ChartPhotocure ASA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Photocure ASA. The current obv is 3,356.

Photocure ASA Daily On-Balance Volume (OBV) ChartPhotocure ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Photocure ASA. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Photocure ASA Daily Money Flow Index (MFI) ChartPhotocure ASA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Photocure ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Photocure ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Photocure ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than504.338
Ma 20Greater thanMa 504.320
Ma 50Greater thanMa 1004.729
Ma 100Greater thanMa 2004.805
OpenGreater thanClose4.320
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Photocure with someone you think should read this too:
  • Are you bullish or bearish on Photocure? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Photocure? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Photocure ASA

I send you an email if I find something interesting about Photocure ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Photocure ASA.

Receive notifications about Photocure ASA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.